Blog

Nermean Mostafa: Great pleasure to participate in RTD Side Event during ESMO 2024

Photo taken from Nermean Mostafa/LinkedIn

Oct 2, 2024, 23:57

Nermean Mostafa: Great pleasure to participate in RTD Side Event during ESMO 2024

Nermean Mostafa, Head of Clinical Oncology unit at Ain shams University, posted the following on LinkedIn:

“It was a great pleasure to actively participate in RTD Side Event during ESMO 2024 about the HCC patient journey. The meeting was a great opportunity to share insights and feedback from stakeholders, patient advocates groups, different members from international Liver communities networking with different representatives from international organizations and societies for better patient outcomes.”

Source: Nermean Mostafa/LinkedIn

cancer ESMO 2024 HCC patient journey international liver communities international organizations Nermean Mostafa networking OncoDaily Oncology patient advocate groups patient outcomes RTD Side Event stakeholder insights

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer